The biomanufacturing industry is on the cusp of a transformative era, driven by technological innovations and strategic financial investments. A recent $7.5 million project agreement awarded to Capra Biosciences by the U.S. Department of Health and Human Services’ Administration for Strategic
Pharmaceutical manufacturing is evolving rapidly to keep pace with increasing global demand and stringent regulatory standards. A critical aspect of this evolution is the integration of automation systems to enhance data integrity. Automation ensures compliance with the ALCOA+
Rentschler Biopharma, a fifth-generation, family-owned German biopharmaceutical company, has made tremendous strides in the field of advanced therapies. With its roots tracing back over 150 years, Rentschler has carved out a unique position in the biotechnology landscape, emphasizing innovation,
Rentschler Biopharma, a renowned contract development and manufacturing organization (CDMO), has recently made significant strides in expanding its facilities and operational capabilities. Located in Milford, Massachusetts, the new addition emphasizes the company's dedication to the burgeoning
The biopharmaceutical industry is in the midst of a significant surge, propelled by concerted expansion efforts, substantial financial investments, and strategic alliances. This dynamic landscape is marked by the growing demand for sophisticated therapeutics, which has led companies to bolster
In a significant move to improve data practices within the biopharmaceutical industry, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has partnered with the Open Applications Group (OAGi). This collaboration aims to overcome the prevalent issue of data
